A compound represented by formula (1) or pharmaceutically acceptable salt thereof: wherein R1 is a C1-6 alkyl group; R2 and R3 are the same or different from each other and each is a hydrogen atom or a C1-6 alkyl group; X2, X3 and X4 are the same or different from each other and each is a hydrogen atom or a halogen atom; and X5 is a hydrogen atom or —P(═O)(OH)2 has a Wnt Pathway modulating activity.
申请公布号
IL245961(D0)
申请公布日期
2016.08.02
申请号
IL20160245961
申请日期
2016.06.01
申请人
EISAI R& D MANAGEMENT CO. LTD.;PRISM PHARMA CO. LTD.